Skip to content

King Pharmaceuticals KG North America — Gross premiums written

Other geography segments

Other (predominantly Europe)
$6.29M

Similar metrics at other companies

Arch Capital Group logo
ACGLNorth America — Net premiums written
$1.43B+17.6%
Chubb logo
CBNorth America Agricultural Insurance — Net premiums written
$311M+12.7%
Chubb logo
CBNorth American Personal P&C Insurance — Net premiums written
$1.68B+8.3%
Chubb logo
CBNorth America Commercial P&C Insurance — Net premiums written
$4.9B+2.3%
American International Group logo
AIGNorth America Commercial — Net Premiums Written
$1.61B+36.7%
Arch Capital Group logo
ACGLNorth America — Net premiums earned
$1.43B+22.0%

Other financials

Income statement

See full
Revenue$10.2M+1,112%
Net income-$7.4M-1,786%
EPS (diluted)-$0.96-586%

Balance sheet

See full
Cash & equivalents$62.2M+1,724%
Total debt$176.7M
Total equity$121.4M+2,773%
Total assets$964.2M

Cash flow

See full
Operating cash flow-$15.1M-1,628%

Valuation

See full
Market cap$70.42M-67.6%
Enterprise value$184.93M-50.0%
P/E1.2×
P/S1.6×-24.3×

Profitability

See full
Net margin131.5%

Returns & leverage

See full
Return on equity90.8%
Debt / equity1.5×

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PremiumsWrittenGross.

The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's north america — gross premiums written.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is King Pharmaceuticals's north america — gross premiums written?
King Pharmaceuticals (KG) reported north america — gross premiums written of -$48.75K in Q4 2025.
What does north america — gross premiums written mean?
This metric represents the total amount of premiums on insurance policies written by the North American segment before accounting for reinsurance cessions. It serves as a primary indicator of the segment's top-line growth and market penetration within the region. Monitoring this figure helps investors assess the scale of business origination and the company's competitive reach in the North American insurance market.